Amble vs PeterMD
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Amble
Best for mainstream telehealth GLP-1 accessStarting at $179/mo
PeterMD
Best for men seeking flat-priced compounded GLP-1 access alongside TRT or peptide therapyStarting at $135/mo
Side-by-Side Comparison
| Feature | Amble | PeterMD |
|---|---|---|
| Overall Score | ✓7.4/10 | 7.2/10 |
| Starting Price | $179/mo | ✓$135/mo |
| Editorial Rating | ✓3.7 ★ /5 | 3.6 ★ /5 |
| Features | 3 features | ✓6 features |
| States Available | ✓50 | 42 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Amble
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
PeterMD
Pros
- ✓Flat pricing across semaglutide dose tiers (0.25mg through 2.4mg)
- ✓Both semaglutide and tirzepatide available
- ✓No long-term commitment after the 2-month intro period
- ✓Month-to-month cancellation via patient portal, no cancellation fee
- ✓Covers men's-health adjacencies (TRT, peptides, ED, anti-aging) in one account
Cons
- ✗Initial $270 two-month payment is non-refundable
- ✗Not available in 8 states (AL, AR, CA, HI, ID, MI, NC, TX)
- ✗Men's-only branding — will not appeal to women seeking GLP-1 access
- ✗Pharmacy partner and named clinicians not publicly disclosed
Our Verdict
Amble edges out PeterMD with a higher overall score of 7.4/10 and is particularly strong for mainstream telehealth GLP-1 access. PeterMD remains a solid alternative, especially if you're looking for men seeking flat-priced compounded GLP-1 access alongside TRT or peptide therapy.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.